Why the study?
Increasing coexistence of cardiovascular diseases and malignancies, alongside treatment-related cardiovascular injury, creates management challenges requiring evaluation of cardio-oncology units, particularly in developing countries.
Highlights the necessity, objectives, and special considerations for establishing cardio-oncology units in developing countries to manage the growing overlap of cardiovascular diseases and cancer.
Answers are grounded in this paper and cite their sources.
Supports integrated cardio-oncology programs for rising cancer-CVD overlap; leaves open evidence-based protocols from prospective trials.
Cardiovascular diseases constitute one of the main aetiologies of mortality among patients with cancer. Population ageing and cancer survival rate improvements have resulted in the coexistence of cardiovascular diseases and malignancies in an increasing number of patients. With the diversity in treatments and the introduction of new drug lines, multiple mechanisms of cardiovascular injury have been recognized in these patients. Cardio-oncology is an emerging entity introduced to provide a proper solution to the several challenges encountered in the management of patients with cancer and cardiac involvement. This review will assess the logical grounds for establishing a cardio-oncology unit, describe the main objectives and the detailed responsibilities in such systems, and outline the target population. Furthermore, the importance of research and appropriate data collection will be highlighted. Lastly, the special considerations and modifications required for setting up such centres in the developing countries are discussed.
No takes yet. Share an insight, caveat, or question.
Alizadehasl et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: